The story
Why we're doing this.
I manage a chronic illness with plant medicine. I know what it does for me. I also know what it's worth without evidence behind it — nothing, to a doctor.
Christine De La Rosa
Founder, The People's Therapeutics
[Replace with your founder story.] The People's Therapeutics became a plant therapeutics company because the gap was obvious: the communities relying on plant-derived compounds most were represented in the research least.
Flavin Plus is the first formulation we're taking into a human trial. GPCOR exists so the data those participants generate belongs in a registry built to serve them, not to disappear into someone else's database.
[Add a closing line about what you're building next.]